Clinical Trial Detail

NCT ID NCT01621477
Title T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements no
Sponsors St. Jude Children's Research Hospital
Indications

non-Hodgkin lymphoma

acute myeloid leukemia

bone marrow cancer

acute lymphocytic leukemia

Hodgkin's lymphoma

chronic myeloid leukemia

juvenile myelomonocytic leukemia

Therapies

Plerixafor

Tacrolimus

Mycophenolate mofetil

Busulfan + Clofarabine + Thymoglobulin

Cyclophosphamide + Cytarabine

Age Groups: child adult

No variant requirements are available.